Description
Baricitinib, also known by its generic name Baricinix, is a Janus kinase (JAK) inhibitor used in the treatment of rheumatoid arthritis. This medication works by blocking the action of Janus kinase enzymes, which play a key role in the inflammation that leads to the symptoms of rheumatoid arthritis.
Benefits of Baricinix (Baricitinib):
Baricinix helps alleviate symptoms such as pain, stiffness, and swelling in the joints while also helping to prevent further joint damage caused by rheumatoid arthritis. Many patients experience noticeable improvements within the first 12 weeks of treatment.
Indications for Use:
Baricinix (baricitinib) is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have had an inadequate response to, or are intolerant to, one or more disease-modifying anti-rheumatic drugs (DMARDs). It can be used as a monotherapy or in combination with Methotrexate.
